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A B S T R A C T
A cDNA encoding the chicken orthologue of dendritic cell-lysosomal associated membrane protein (DC-
LAMP)/CD208 was cloned by RT-PCR from RNA isolated from mature chicken bone marrow-derived
dendritic cells (chBM-DCs). The cloned chicken DC-LAMP (chDC-LAMP) cDNA consists of 1281
nucleotides encoding an open reading frame of 426 amino acids (aa). Comparison of the deduced aa
sequence of DC-LAMP with orthologous proteins from human and mouse revealed 27 and 24% identity,
respectively. The predicted chDC-LAMP protein shares the characteristic features of LAMP family
members. ChDC-LAMP mRNA, unlike its mammalian orthologues, was expressed in a wide range of
tissues, at highest levels in the lung. Lymphoid tissues including thymus, spleen, bursa, ceacal tonsil and
Meckel’s diverticulum had high chDC-LAMPmRNA expression levels. ChDC-LAMPmRNAwas expressed
in all splenocyte subsets with the highest expression in Bu-1+ B cells and KUL01+ cells, which would
includemacrophages and DC. ChDC-LAMPmRNAwas highly expressed in chBM-DC, whereas expression
levels in chicken monocyte-derived macrophages (chMo-Mac) and the HD11 macrophage cell line were
signiﬁcantly lower. Following CD40L stimulation, chDC-LAMP mRNA expression levels were up-
regulated in mature chBM-DC, chMo-Mac and HD11 cells whereas lipopolysaccharide (LPS) only up-
regulated chDC-LAMP mRNA expression levels in chBM-DC. ChDC-LAMP is not solely expressed on
chicken DC but can be used as a marker to differentiate between immature and mature DC.
 2009 Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Developmental and Comparative Immunology
journa l homepage: www.e lsev ier .com/ locate /dc i1. Introduction
Dendritic cells (DCs) are professional antigen-presenting cells
with the unique function to activate primary immune responses
[1,2]. Immature DCs, equipped with numerous receptors, are
specialized in antigen capturing and processing. Inmammals, upon
activation by pathogen associated molecular patterns they
undergo phenotypic changes and migrate into T-cell regions of
secondary lymphoid tissues, where they complete their matura-
tion and become specialized in presenting collected antigens to T
cells to initiate adaptive immune responses. The phenotypes of DC
in mammalian biomedical model species are well deﬁned and
some markers can be used to differentiate immature DC andAbbreviations: aa, amino acids; BM-DC, bone marrow-derived dendritic cells; ch,
chicken; Chr., chromosome; CS, chicken serum; Ct, threshold cycle value; DCs,
dendritic cells; DC-LAMP, dendritic cell-lysosomal associated membrane protein;
GM-CSF, granulocyte-macrophage colony-stimulating factor; hps, hours post-
stimulation; hu, human; IL-4, interleukin-4; LPS, lipopolysaccharide; m, murine;
MHC, major histocompatibility complex; Mo-Mac, monocyte-derived macro-
phages; PBS, phosphate-buffered saline.
* Corresponding author. Tel.: +44 1635 578411; fax: +44 1635 577263.
E-mail address: zhiguang.wu@bbsrc.ac.uk (Z. Wu).
0145-305X/$ – see front matter  2009 Elsevier Ltd. All rights reserved.
doi:10.1016/j.dci.2009.09.007mature DC. Mature DC express up-regulated levels of major
histocompatibility complex (MHC) class II and co-stimulatory
molecules. The most speciﬁc markers for mature human DC are
CD83 [3] and dendritic cell-lysosomal associated membrane
protein (DC-LAMP) [4].
DC-LAMP/CD208 is a member of the LAMP family and is used as
a speciﬁc marker of mature human, but not murine, DC [4,5]. In
human DC, DC-LAMP is associated with the intracellular MHC II
compartment and plays a role in the transfer of MHC class II
molecules to the cell surface [4,6]. DC-LAMP is also used as a
marker of mature DC in other mammals, including cattle [7] and
pigs [8].
ChickenDC generated frombonemarrowprecursors has typical
morphological, phenotypical and functional characteristics of DC
[9]. Immature chicken bone marrow-derived DC (chBM-DC)
showed high surface expression of MHC class II+ and putative
CD11c, moderate or low levels of co-stimulatorymolecules, and no
surface expression of CD83 or DEC205. LPS- and CD40L-stimulated
mature chBM-DC had elevated surface expression levels of co-
stimulatory molecules (CD40 and CD86), CD83 and DEC205,
compared to those seen on non-stimulated immature chBM-DC. In
the hope of deﬁning a novel marker for mature chicken DC, we
have identiﬁed the chicken orthologue of DC-LAMP and investi-
Table 1
Real-time quantitative RT-PCR probes and primers.
RNA
target











a F= forward primer; R = reverse primer.
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subsets and immature and mature chBM-DC.
2. Materials and methods
2.1. Cloning of chicken DC-LAMP
The chDC-LAMP cDNA was predicted based on nucleotide
sequence homology to human DC-LAMP sequences in Ensembl
using BLAST (http://www.ensembl.org/Multi/blastview). Primers
were designed according to the predicted sequence; forward
primer (DC-LAMP F), 50-ATGGGAAGGAGCAAATCACACT-30 and
reverse primer (DC-LAMP R), 50-TCAGATGTCCAAAAAGTCTT-30.
RNA from mature chBM-DC (see later) was used as RT-PCR
template. First strand synthesis was for 50 min at 42 8C in a 20 ml
volume containing 4 pmol of oligo dT, 200 U Superscript II
(Invitrogen, Paisley, UK) and 500 ng chBM-DC RNA. After
denaturation of the reverse transcriptase at 94 8C for 3 min, 2 ml
of this reaction mix were added as template to a 20 ml PCR
reaction, containing 20 pmol of each forward and reverse primer,
0.4 mM dNTPs, 1 ml Taq polymerase (Invitrogen). Cycling condi-
tionswere 30 cycles of 94 8C for 1 min, 58 8C for 1 min and 72 8C for
1 min.
2.2. Preparation of tissues and splenocyte subsets
Tissues and splenocyte subsets were obtained from three 6-
week-old inbred line 72 chickens. The inbred line 72 originated
from the Regional Poultry Research Laboratory (East Lansing, MI)
and is a White Leghorn line maintained at the Institute for Animal
Health (Compton, UK) [10,11]. Lymphoid tissues included thymus,
spleen, bursa, Harderian gland, caecal tonsil,Meckel’s diverticulum
and bone marrow and non-lymphoid tissues included brain,
muscle, heart, liver, kidney, lung and skin. Splenocyte subsets were
isolated as described before [12,13]. Brieﬂy, chicken spleens were
digested with 556mg/ml DNase I (Roche Diagnostics Ltd., Burgess
Hill, West Sussex, UK) and 2.2 mg/ml collagenase D (Roche
Diagnostics Ltd.) in Hank’s Buffered Salt Solution for 1 h. Single
cell suspensions were extracted using Histopaque 1077 (Sigma–
Aldrich, Poole, UK) followed by three washes in PBS. 1  108 cells
were labelled with mouse anti-chicken CD4, CD8, Bu-1, TCR1,
TCR2, TCR3, or KUL01 monoclonal antibodies (SouthernBiotech,
Birmingham, Alabama, USA). Polyclonal goat anti-mouse IgG-
coated microbeads (Miltenyi Biotec, Bisley, Surrey, UK) were used
to isolate labelled cells by a standard positive selection (POSSEL)
using an autoMACSpro separator (Miltenyi Biotec).
2.3. Culture of chicken bone marrow-derived dendritic cells, blood-
derived monocyte-macrophages and the HD11 cell line
ChBM-DC was isolated as described previously [9]. Brieﬂy,
chicken bone marrow cells were cultured in the presence of
recombinant chicken granulocyte-macrophage colony-stimulating
factor (GM-CSF) and recombinant chicken interleukin-4 (IL-4).
Recombinant chicken GM-CSF and IL-4 were produced from COS-7
cells transfected with pCIneo (Promega, Southampton, UK) expres-
sing the relevant cytokine. There are no internationally agreed units
of activity for avian cytokines. COS cell culture supernatants which
contained chicken GM-CSF or IL-4 were both used at a dilution of
1:250 to maximise the number of cell aggregates. Immature chBM-
DC aggregates started to grow fromday 4. On day 6, LPS (Escherichia
coli055:B5, 200 ng/ml; Sigma–Aldrich) orCD40L (3mg/ml) [14]was
used to stimulate immature chBM-DC during a 48 h time-course.
Non-stimulated or stimulated chBM-DC was harvested at different
time-points for RNA preparation. Separate RNA preparations were
isolated from chBM-DC from three different birds. RNA from chBM-DCstimulatedwith LPS for 24 hwasusedas template to clone chDC-
LAMP cDNA.
Chicken monocyte-derived macrophages (chMo-Mac) were
isolated from peripheral blood of three 6-week-old inbred line 72
chickens. Ten millilitres of blood (with K3EDTA as anti-coagulant)
were diluted with PBS and centrifuged over Histopaque 1083
(Sigma–Aldrich) at 1200  g for 40 min. The interface was
collected, washed and adjusted to 5  106 cells/ml in RPMI 1640
(Invitrogen) with 5% chicken serum (CS) (Invitrogen). Cells were
cultured in 6-well-plates at 41 8C, 5% CO2 overnight and non-
adherent cells were gently removed. Adherent cells were
incubated for a further 24 h and then stimulated with LPS or
CD40L for another 24 h.
The HD11 avian macrophage-like cell line [15] was cultured in
RPMI 1640 (Invitrogen) containing 2.5% foetal calf serum
(Invitrogen), 2.5% CS (Invitrogen), 10% tryptose phosphate broth,
20 mM L-glutamine, 1 U/ml penicillin and 1 mg/ml streptomycin.
HD11 cells were trypsinised, seeded to a 6-well-plate and then
stimulated with LPS or CD40L for 24 h. Unstimulated or stimulated
chMo-Mac and HD11 cells were harvested for RNA preparation.
2.4. Total RNA isolation
RNA from the tissues and cells isolated and cultured as
described above was extracted using an RNeasy Mini kit (QIAGEN,
Crawley, UK) following the manufacturer’s instructions.
2.5. Real-time quantitative RT-PCR analysis of chDC-LAMP
expression
ChDC-LAMP mRNA levels in different tissues and cells were
quantiﬁed using TaqMan real-time quantitative RT-PCR (qRT-PCR),
a well-describedmethod [13,16–18]. ChDC-LAMP-speciﬁc primers
and probe (Table 1) were designed using the Primer Express
software program (Applied Biosystems, Warrington, UK). The
probe lies across the boundary between exons 1 and 2. Primers and
probe for 28S RNA have been described previously but for clarity
are also given in Table 1. The assays were performed using the
TaqMan Fast Universal PCR master mix and one-step RT-PCR
master mix reagents (Applied Biosystems). Data are expressed in
terms of the threshold cycle value (Ct). The chDC-LAMP-speciﬁc
product for each sample was normalised using the Ct value of 28S
rRNA product for the same sample. Final results are shown either
as 40-Ct, using the normalised value, or as fold difference from
levels in control chBM-DC.
3. Results and discussion
3.1. Cloning and sequence analysis of chDC-LAMP
In human, the DC-LAMP gene is encoded on chromosome 3
(Chr. 3). We used the huDC-LAMP sequence to search the chicken
Fig. 1. (A) Conserved synteny between human Chr. 3 and chicken Chr. 9, around DC-LAMP. Genes are shown as boxes, intergenic regions as the lines joining the boxes, neither
being to scale. The human genes are labelled centred above or below the boxes. The same genes are present in the same order in the chicken as in human, with an additional
four chicken genes (labelled and shaded) forwhich there are no obvious human orthologues. (B) Comparison of the gene structures of human (Acc. No. AJ005766),mouse (Acc.
No. NM_177356) and chicken (Acc. No. AM933592) DC-LAMP. Exons are shown as boxes; black boxes represent the UTRs (length unknown in the chicken), open boxes coding
sequence; introns are shown as lines joining the boxes. Numbers represent exon (below) and intron (above) lengths in aa and base-pairs, respectively.
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of the chicken homologue of huDC-LAMP. The gene encoding
chDC-LAMP lies on Chr. 9, in a group of genes with conserved
synteny with human Chr. 3 (Fig. 1A). The full length cDNA of
chicken DC-LAMP consists of 1281 nucleotides encoding an open
reading frame of 426 amino acids (aa) (Acc. No. AM933592). The
gene structure of chDC-LAMP is similar to those of human and
mouse DC-LAMP, comprising six exons and ﬁve introns, with
similar numbers of aa encoded by the respective exons across
species (Fig. 1B). Overall, the gene is less than one-third the length
of huDC-LAMP and one-fourth that of mDC-LAMP.
The predicted chDC-LAMP polypeptide has the typical
features of a type I transmembrane protein. It has a presumptive
signal peptide of 22 aa, as predicted by the SignalP program
(http://www.cbs.dtu.dk/services/SignalP), followed by a long
extra-cellular domain (369 aa), a hydrophobic transmembrane
domain (23 aa), and a short cytoplasmic domain (12 aa), as
predicted by the TMHMM2 program (http://www.cbs.dtu.dk/
services/TMHMM-2.0). ChDC-LAMP also shares characteristic
features of LAMP family members [19,20] (Fig. 2A). Like humanand mouse DC-LAMP, the luminal domain of chDC-LAMP is
divided by a serine/proline-rich region. The membrane-proximal
domain contains four conserved cysteines which have the
potential to form two disulphide bridges. The short C-terminal
cytoplasmic tail contains a conserved tyrosine-based motif (Tyr-
X-X-hydrophobic residue) for lysosomal targeting [21–23].
ChDC-LAMP is also rich in N-glycosylation sites (11 in total). A
phylogenetic tree (Fig. 2B) illustrates the conservation of aa
sequences of LAMP proteins between different species. The tree
indicates that chDC-LAMP is a new member of the chicken LAMP
family and is closer to mammalian DC-LAMP than chLAMP1 or
chLAMP2. Comparison of the deduced aa sequence of chDC-
LAMP with its human and mouse orthologues revealed 27 and
24% identity, respectively.
3.2. Expression of chDC-LAMP in different tissues and splenocyte
subsets
Expression of chDC-LAMP mRNA in lymphoid and non-
lymphoid tissues and splenocyte cell subsets was assessed by
Fig. 2. (A) Alignment of the predicted aa sequence of chicken DC-LAMP (Acc. No. AM933592) with its human (Acc. No. AJ005766) and mouse (Acc. No NM_177356)
orthologues. Shaded areas represent conservation of aa similarity. Gaps introduced for optimal alignment are indicated by dashes. The potential N-glycosylation sites
in chDC-LAMP are underlined. The conserved cysteines are indicated with asterisks. The conserved serine/proline-rich region is underlined with a dotted line. The conserved
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Fig. 4. (A) Expression patterns of chDC-LAMPmRNA, asmeasured by real-time qRT-
PCR, with results expressed as 40-Ct values  SE, in chBM-DC, chMo-Mac and HD11
cells which were unstimulated (Ctl) or stimulated with LPS or CD40L for 24 h. (B)
Expression patterns of chDC-LAMPmRNA, as fold-change from levels in time-matched
unstimulated (Ctl) chBM-DC, in chBM-DC stimulated with LPS or CD40L during a time-
course. hps = hours post-stimulation. (*) Levels are statistically signiﬁcantly different
at p < 0.05 when compared with levels in unstimulated (Ctl) chBM-DC.
Fig. 3. Expression patterns of chDC-LAMP mRNA, as measured by real-time qRT-
PCR, with results expressed as 40-Ct values  SE. A. Expression in chicken lymphoid
(1–) and non-lymphoid (8–5) tissues; 1, thymus; 2, spleen; 3, bursa of Fabricius; 4,
Harderian gland; 5, caecal tonsil; 6, Meckel’s diverticulum; 7, bonemarrow; 8, brain; 9,
muscle; 10, heart; 11, liver; 12, kidney; 13, lung; 14, skin; 15, small intestine. (B)
Expression in chicken splenocyte subsets.
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expressed in all the lymphoid and non-lymphoid tissues tested
except for muscle. Amongst lymphoid tissues, chDC-LAMP mRNA
was most highly expressed in the thymus, spleen, bursa, ceacal
tonsil and Meckel’s diverticulum. In non-lymphoid tissues, it was
most highly expressed in the lung. In human, mouse and sheep,
DC-LAMPmRNA is highly expressed in the lung and is described as
a marker of adult type II pneumocytes in those species [4,5,24,25].
In human, lymphoid organs are major sources of DC-LAMP mRNA
[4]. However, in themouse, only lymphnodes and the spleen, other
than the lung, express DC-LAMP mRNA, at very low levels,
contrasting with the expression of DC-LAMP mRNA in human [5]
and the chicken.
In human, DC-LAMP mRNA is speciﬁcally expressed in DC and
is up-regulated after DCmaturation and activation. Among freshly
isolated cells, DC-LAMP is only present in resting or phorbol
myristate acetate-ionomycin-activated DC, but not in activated
monocytes, T cells, granulocytes, peripheral blood lymphocytes
and B cells [4]. However, chDC-LAMP mRNA was detected in all
splenocyte subsets (Fig. 3B), although for CD4+, CD8+, TCR1+,
TCR2+ and TCR3+ subsets, the expression levels were compara-
tively and signiﬁcantly lower than in Bu-1+ and KUL01+
splenocytes. Chicken Bu-1 is a marker for chicken B cells and is
also expressed on subsets ofmacrophages andmonocytes [26,27].
The monoclonal antibody KUL01 identiﬁes chicken monocytes
and macrophages as well as interdigitating cells and activated
microglia cells and is considered to be a marker for chicken
monocytes and macrophages [28,29]. Our unpublished data also
suggest that it recognises chBM-DC. Our results suggest that
unlike mammalian DC-LAMP, chDC-LAMP mRNA may also be
expressed in chicken B cells and macrophages.C-terminal tyrosine-based lysosomal targeting motif (Tyr-X-X-hydrophobic residue) is d
DC-LAMP, CD68, LAMP1 and LAMP2 from human (hu), mouse (m), bovine (bov) and ch
advance 11 program (Invitrogen). Accession numbers are as above and as follows: bovD
NM_010684 ; chLAMP2, NM_001001749 ; huLAMP2, BC002965 ; mLAMP2, NM_001013.3. Expression of chDC-LAMP in chicken DC and macrophages
ChDC-LAMP mRNA expression levels were measured in in vitro
cultured chBM-DC, ex vivo chMo-Mac and HD11 cells (Fig. 4A).
ChDC-LAMP mRNA was highly expressed in unstimulated chBM-
DC but also signiﬁcantly up-regulated after stimulationwith LPS or
CD40L for 24 h. As characterised recently [9], unstimulated chBM-
DC are primarily immature DC, and LPS and CD40L drive chBM-DC
maturation. Similarly, human DC-LAMP mRNA is up-regulated
after DC maturation and activation [4,30]. When compared with
chBM-DC, DC-LAMP mRNA expression levels in chMo-Mac and
HD11 cells were signiﬁcantly lower. CD40L, but not LPS,
stimulation up-regulated the expression of chDC-LAMP mRNA in
chMo-Mac and HD11 cells.
Fig. 4B shows the mRNA expression pattern of chDC-LAMP in
chBM-DC during a time-course after stimulation with LPS or
CD40L. ChDC-LAMP mRNA was signiﬁcantly up-regulated after
stimulation with LPS after 4 h and with CD40L after 12 h. The up-
regulation continued until 48 h post-stimulation, by which time-
point most chBM-DC in similar stimulation assays were mature
[9]. The kinetics of up-regulation of chDC-LAMP mRNA after
maturation of chBM-DC were similar to those for DC-LAMP mRNA
in human CD34+ cell-derived DC and monocyte-derived DC [4,30].
However, our results were in contrast to the expression pattern of
DC-LAMP in mouse DC, in which DC-LAMP was never detected, no
matter the source of cells (in vitro-derived, ex vivo-puriﬁed or in
vivo) or the type of activation [5]. Our results on cell and tissue
expression suggest that chDC-LAMP may not be a speciﬁc markerouble-underlined. B. Unrooted phylogenetic tree of LAMP family proteins including
icken (ch). Branch lengths are derived from distances estimated by the Vector NTI
C-LAMP, NM_001102135 ; chLAMP1, NM_205283 ; huLAMP1, J04182 ; mLAMP1,
7959 ; huCD68, NM_001251 ; mCD68, BC021637.
Z. Wu et al. / Developmental and Comparative Immunology 34 (2010) 183–188188for chicken DC, although this needs more thorough investigation.
However, its expression is up-regulated on mature vs. immature
DC, suggesting that, as in human, it can be used as a marker to
differentiate between antigen-sampling and antigen-presenting
DC.
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